425: Strive & Semler Scientific Merger Update

Strive CEO Matthew Cole provided an update on X.com regarding the proposed business combination with Semler Scientific, Inc.

Summary

• Strive, Inc. CEO Matthew Cole posted a communication on X.com on September 23, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication serves as a cautionary statement regarding forward-looking statements related to the merger.
• It highlights the proposed transaction's outlook, expected strategic and financial benefits, timing of closing, and successful integration of combined businesses.
• Investors are advised to read the Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, for important information.

Sentiment

Score: 5

Explanation: The filing is a procedural update for a proposed merger, heavily emphasizing forward-looking statements and a comprehensive list of associated risks. It does not present new financial performance data, leading to a neutral-to-cautious sentiment.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• The combined company anticipates successful integration of the businesses.

Negatives

• No specific negative financial or operational results are reported in this filing, as it pertains to a proposed future event.

Risks

• The occurrence of any event, change, or circumstance that could lead to termination of the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to unfulfilled conditions.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The outlook for the proposed transaction includes expectations for strategic and financial benefits, successful integration of the combined businesses, and the timing of the closing. However, these are subject to inherent risks and uncertainties, and actual results could differ materially from anticipated outcomes.

Management Comments

• Matthew Cole, CEO of Strive, Inc., posted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The filing mentions risks associated with 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' indicating that the combined entity may be pursuing or expanding into digital asset strategies. This aligns with a broader trend of companies exploring or adopting digital assets for treasury management or as part of their strategic operations.

Corporate Governance

Legal Proceedings

• The filing identifies the 'outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company' as a risk factor, but does not detail any current legal proceedings.

Related Party Transactions

• The filing refers to Semler Scientific's definitive proxy statement for its 2025 Annual Meeting of Stockholders for information on 'Transactions with Related Persons,' but does not disclose new related party dealings.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock for the merger.
• Customers and employees of both Strive and Semler Scientific could experience adverse reactions or changes to business or employee relationships as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock for the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Key Dates

Recommendation

The filing is a procedural update regarding a proposed business combination, emphasizing forward-looking statements and associated risks. It lacks specific financial performance data or new strategic initiatives beyond the merger itself. Investors would likely hold their positions pending the full details of the merger, including financial projections and integration plans, which will be available in the Form S-4.

Keywords

Strive, Semler Scientific, merger, business combination, acquisition, SEC filing, Form 425, forward-looking statements, Bitcoin treasury, digital assets, corporate governance, investment